Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 729

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 729
---
 and 2023 fiscal years to our named executive officers.

    Name
    and principal position 
    Year  
    Salary
    ($)  
    Bonus
    ($)  
    Stock
    Awards ($)  
    Option
    Awards ($) (6)  
    Non-Equity
    Incentive Plan Compensation ($)  
    Nonqualified
                                            Deferred Compensation Earnings ($)  
    All
    Other Compensation ($)  
    Total ($) 
  
    Erez
    Aminov, 
    2024  
     259,999  
     300,000  (1) 
     595,000 (2) 
     1,919,120  
           -  
           -  
     66,194 (3) 
     3,140,313 
  
    CEO 
    2023  
     83,333  
     208,006 (4) 
     -  
     1,368,600  
     -  
     -  
     5,625 (5) 
     1,665,564 

    Michelle
    Yanez, 
    2024  
     158,219  
     -  
     -  
     258,900  
     -  
     -  
     26,902 (5) 
     444,021 
  
    CFO 
    2023  
     165,000  
     88,475 (4) 
     -  
     282,215  
     -  
     -  
     5,934 (5) 
     541,624 

    (1)

    The
                                            amounts represent bonus earned as part of CEO Executive Scorecard

    (2)
    On
    December 6, 2024, Mr. Aminov was awarded an RSU Stock Award
  
    (3)
    Amount
    represents health insurance premiums paid, car payments, car insurance, and club memberships
  
    (4)
    
    Amount
                                            represents IPO bonus paid

    (5)
    Amounts
    represent health insurance premiums paid
  
    (6)
    The
    reported amounts represent the aggregate grant date fair value of the awards computed in accordance with Financial Accounting